Impact of chemotherapy on disseminated low‐grade glioma in children and adolescents: Report from the HIT‐LGG 1996 trial
- 11 February 2011
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 56 (7) , 1046-1054
Abstract
Background: We describe demographic data of disseminated childhood low‐grade glioma (DLGG) prospectively recruited in the HIT‐LGG 1996 study and evaluate the impact of primary chemotherapy (CT) on the outcome of these tumors, which have previously only been described in small and retrospective series.Patients and Methods: The multicenter study HIT‐LGG 1996 accrued 1181 children and adolescents with low‐grade glioma. 61 patients (5.2%) had tumor dissemination, with 2.8% being present at diagnosis. Frequencies of dissemination for different subgroups were calculated. Efficiency of first‐line CT with vincristine/carboplatin was defined in 24 children with dissemination prior to first‐line non‐surgical‐treatment.Results: Incidence of dissemination was high among infants (16%) with hypothalamic‐chiasmatic‐glioma (HCG) and diencephalic syndrome. A relevant percentage of HCG showed isolated spinal dissemination. CT achieved objective and overall response rates of 25% and 79% of the primary tumor and a similar response of disseminated lesions. Clinical stabilization or improvement could be achieved in the majority of patients during treatment. However, 20 of 24 patients experienced further progression and 5‐year PFS was 6%. Dissemination prior to CT was a negative prognostic factor for PFS within the study (P = 0.005).Overall‐survival of primary DLGG was inferior compared to LGG without dissemination at diagnosis (P < 0.001).Conclusion: Complete MRI scan should be a standard diagnostic procedure in young children with hypothalamic‐chiasmatic tumors especially if presenting with diencephalic syndrome. Dissemination in childhood LGG relates to impaired PFS. CT delays progression for responders. Multicenter studies have to evaluate the efficacy of extended treatment strategies in DLGG to improve outcome. Pediatr Blood Cancer 2011;56:1046–1054.Keywords
Funding Information
- Deutsche Krebshilfe (70-2288-Gn1)
This publication has 36 references indexed in Scilit:
- BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomasJournal of Clinical Investigation, 2008
- Cervico‐medullary desmoplastic infantile ganglioglioma: An unusual case with diffuse leptomeningeal dissemination at diagnosisPediatric Blood & Cancer, 2005
- Progression-Free Survival in Children With Optic Pathway Tumors: Dependence on Age and the Quality of the Response to Chemotherapy—Results of the First French Prospective Study for the French Society of Pediatric OncologyJournal of Clinical Oncology, 2003
- Study of the MIB-1 Labeling Index as a Predictor of Tumor Progression in Pilocytic Astrocytomas in Children and AdolescentsJournal of Clinical Oncology, 2003
- Leptomeningeal dissemination in children with progressive low-grade neuroepithelial tumorsNeuro-Oncology, 2002
- Fatal pleomorphic xanthoastrocytoma with meningeal gliomatosisHistopathology, 1998
- Low-grade astrocytoma with neuraxis dissemination at diagnosisJournal of Neurosurgery, 1995
- Recommendations of the brain tumor subcommittee for the reporting of trialsMedical and Pediatric Oncology, 1995
- Treatment options and prognosis for multicentric juvenile pilocytic astrocytomaJournal of Neurosurgery, 1994
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958